Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Management of Descending Aortic Aneurysm with Concomitant PAU and IMH

Initial Medical Management

  • The European Society of Cardiology recommends immediate aggressive medical therapy with blood pressure control (systolic <120 mmHg) and heart rate control (≤60 bpm) in patients with a descending thoracic aortic aneurysm accompanied by both penetrating aortic ulcer (PAU) and intramural hematoma (IMH), followed by urgent thoracic endovascular aortic repair (TEVAR) 1, 2, 3
  • Initiate intravenous beta-blockers immediately to achieve target heart rate ≤60 beats per minute before addressing blood pressure, as vasodilators given before heart rate control can provoke reflex tachycardia that increases aortic wall stress 3
  • Target blood pressure is systolic <120 mmHg and diastolic <80 mmHg 3
  • Provide adequate analgesia as pain control is essential and uncontrolled pain may indicate disease progression 1, 2

Risk Stratification and Imaging

  • The presence of PAU with associated IMH significantly increases the risk of treatment failure and adverse outcomes compared to isolated PAU, with high-risk imaging features including maximum PAU width ≥13-20 mm 1
  • Maximum PAU depth ≥10 mm is a high-risk feature 1, 2
  • PAU associated with saccular aneurysm is a high-risk feature 1
  • Increasing pleural effusion is a high-risk feature 1
  • Significant growth of PAU width or depth >5 mm/year is a high-risk feature 1
  • Contrast-enhanced computed tomography (CT) is the diagnostic technique of choice with 96% sensitivity for detecting IMH 1, 4, 5
  • Perform immediate CT imaging without delay to assess extent of disease and identify high-risk features 6, 5

Definitive Treatment Strategy

  • Given the combination of aneurysm with both PAU and IMH in the descending aorta, this represents a complicated type B acute aortic syndrome requiring endovascular intervention 1, 2
  • Complicated type B PAU with IMH warrants TEVAR as first-line therapy 1, 3, 2
  • Urgent TEVAR should be performed once hemodynamic stability is achieved rather than delayed elective repair 1, 2
  • Persistent or recurrent pain despite medical therapy mandates immediate intervention 1
  • Evidence of disease progression on repeat imaging (hematoma expansion, periaortic hematoma, intimal disruption) requires urgent treatment 1, 2

Long-Term Management Post-Intervention

  • Follow-up imaging at 1, 3, 6, and 12 months after intervention, then yearly if stable 7
  • Use CT or CMR for surveillance 1, 2
  • Continue strict blood pressure control indefinitely with target systolic <120 mmHg 3
  • Maintain heart rate control with beta-blockers 3
  • Initiate moderate- to high-intensity statin therapy with LDL-C goal <55 mg/dL (<1.4 mmol/L) given atherosclerotic disease 3
  • Consider low-dose aspirin (75-162 mg/day) to reduce cardiovascular events 3
  • Monitor for late aneurysm formation or dissection progression 2

REFERENCES

3

Management of Penetrating Aortic Ulcer [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Acute Aortic Syndrome: Penetrating Ulcer in Left Common Iliac Artery with Intramural Hematoma [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Acute Aortic Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

acr appropriateness criteria® suspected acute aortic syndrome. [LINK]

Journal of the American College of Radiology, 2021